These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 33393013)

  • 1. Efficacy Comparison for a Schizophrenia and a Dysuria Drug Among East Asian Populations: A Retrospective Analysis Using Multi-regional Clinical Trial Data.
    Sai K; Nakatani E; Iwama Y; Hiraoka S; Tohkin M; Uyama Y; Saito Y
    Ther Innov Regul Sci; 2021 May; 55(3):523-538. PubMed ID: 33393013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of Asian Participation in Multi-regional Clinical Trials Reviewed for Drug Approval in Japan: Opportunities for Collaboration Between South-East Asia, East Asia, and Japan.
    Aoi Y; Kato Y; Asano K; Otsubo Y; Uyama Y
    Ther Innov Regul Sci; 2023 Nov; 57(6):1298-1303. PubMed ID: 37587270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population/regional differences in efficacy of 3 drug categories (antidiabetic, respiratory and psychotropic agents) among East Asians: A retrospective study based on multiregional clinical trials.
    Sai K; Yoshida A; Hanatani T; Imatoh T; Takeuchi M; Narukawa M; Watanabe H; Uyama Y; Saito Y
    Br J Clin Pharmacol; 2019 Jun; 85(6):1270-1282. PubMed ID: 30735569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Drug Lags in Development Initiation, New Drug Application and Approval Between Japan and the USA and the Impact of Local Versus Multi-regional Clinical Trials.
    Ushijima S; Matsumaru N; Tsukamoto K
    Pharmaceut Med; 2021 Jul; 35(4):253-260. PubMed ID: 34291425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The necessary conduct: Exploratory multiregional clinical trials in East Asia.
    Jeon I; Kim YK; Song I; Yoon DY; Huh KY; Jin X; Yu KS; Lee S; Kumagai Y; Jang IJ
    Clin Transl Sci; 2021 Nov; 14(6):2399-2407. PubMed ID: 34397152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of estimand framework to the design and analysis of multi-regional clinical trials.
    Niu C; Liang L; Fu R; Zhong W; Wang WWB
    J Biopharm Stat; 2024 Jun; ():1-17. PubMed ID: 38840476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Points to Consider for Implementation of the ICH E17 Guideline: Learning from Past Multiregional Clinical Trials in Japan.
    Asano K; Aoi Y; Kamada S; Uyama Y; Tohkin M
    Clin Pharmacol Ther; 2021 Jun; 109(6):1555-1563. PubMed ID: 33245786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asia-Inclusive Clinical Research and Development Enabled by Translational Science and Quantitative Clinical Pharmacology: Toward a Culture That Challenges the Status Quo.
    Venkatakrishnan K; Gupta N; Smith PF; Lin T; Lineberry N; Ishida T; Wang L; Rogge M
    Clin Pharmacol Ther; 2023 Feb; 113(2):298-309. PubMed ID: 35342942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Consistency of Treatment Response Across Regions-the LEADER Trial in Relation to the ICH E17 Guideline.
    Nielsen HK; DeChiaro S; Goldman B
    Front Med (Lausanne); 2021; 8():662775. PubMed ID: 34136501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Drug Characteristics for Implementing Multiregional Clinical Trials Including Japan.
    Rokuda M; Matsumaru N; Tsukamoto K
    Clin Ther; 2018 Feb; 40(2):284-295. PubMed ID: 29361305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential Future Drug Development Lag in Japan Based on an Analysis of Multiregional Clinical Trials in the US, Europe, and East Asia.
    Noguchi A; Hanaoka H; Uyama Y
    Ther Innov Regul Sci; 2022 May; 56(3):523-529. PubMed ID: 35181842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Similarities and differences in diagnosis and treatment of gastrointestinal stromal tumors between China, Japan and Korea: from expert consensus to cooperation prospect].
    Cao H; Wang M
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Sep; 22(9):812-819. PubMed ID: 31550818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asia-Inclusive Global Development of Enpatoran: Results of an Ethno-Bridging Study, Intrinsic/Extrinsic Factor Assessments and Disease Trajectory Modeling to Inform Design of a Phase II Multiregional Clinical Trial.
    Klopp-Schulze L; Gopalakrishnan S; Yalkinoglu Ö; Kuroki Y; Lu H; Goteti K; Krebs-Brown A; Nogueira Filho M; Gradhand U; Fluck M; Shaw J; Dong J; Venkatakrishnan K
    Clin Pharmacol Ther; 2024 Jun; 115(6):1346-1357. PubMed ID: 38415785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Summary Report of a Public Workshop: Case Studies of Multi-Regional Clinical Trial Incorporating Concept of the ICH E17 Guideline.
    Matsushima N; Otsubo Y; Aoi Y; Nakamura R; Kaneko S; Asakawa T; Matsuoka N; Watabe K; Komiyama O; Yamamoto H; Ando Y
    Clin Pharmacol Ther; 2024 May; 115(5):965-970. PubMed ID: 38251824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of global versus Asian clinical trial strategies supportive of registration of drugs in Japan.
    Shirotani M; Kurokawa T; Chiba K
    J Clin Pharmacol; 2014 Jul; 54(7):753-64. PubMed ID: 24496890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence Diagnostics of a Region of Interest in Multi-regional Clinical Trials.
    Kuribayashi K; Cao C
    Ther Innov Regul Sci; 2023 Mar; 57(2):220-226. PubMed ID: 36109434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bayesian joint models for multi-regional clinical trials.
    Bean NW; Ibrahim JG; Psioda MA
    Biostatistics; 2024 Jul; 25(3):852-866. PubMed ID: 37669215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of efficacy outcomes of anticancer drugs between Japanese patients and the overall population.
    Tamai T; Kaneko M; Narukawa M
    Int J Clin Oncol; 2021 Feb; 26(2):296-304. PubMed ID: 33057897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of a Common Data Model (CDM) to rank the paediatric user and prescription prevalence of 15 different drug classes in South Korea, Hong Kong, Taiwan, Japan and Australia: an observational, descriptive study.
    Brauer R; Wong ICK; Man KK; Pratt NL; Park RW; Cho SY; Li YJ; Iqbal U; Nguyen PA; Schuemie M
    BMJ Open; 2020 Jan; 10(1):e032426. PubMed ID: 31937652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional efficacy evaluation in multi-regional clinical trials using a discounting factor weighted Z test.
    Yu X; Cai L; Yu H; Zhong Z; Yang M; Wu J; Bai J
    Pharm Stat; 2023 Mar; 22(2):266-283. PubMed ID: 36317256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.